Skip to main content

Treatment of Hepatitis C Virus-Associated Chronic Liver Disease with ß-Interferon and Inosine Pranobex: Combination Schedule vs Monotherapies

  • Chapter
Combination Therapies 2

Abstract

The recently identified hepatitis C virus (HCV)1 is responsible for almost 90% of cases of chronic post-transfusion non-A, non-B hepatitis and for more than 70% of sporadic cases2. Acute NANB hepatitis becomes chronic in 50% of cases3 and 20–30% of them progress to cirrhosis4.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Q.L. Choo, G. Kuo, A.J. Weiner, L.R. Overby, D.W. Bradley, M. Houghton, Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome, Science 244: 359 (1989).

    Article  PubMed  CAS  Google Scholar 

  2. D.Sansonno, F. Dammacco, Antibodies to hepatitis C virus in non-A, non-B post-transfusion and cryptogenic chronic liver disease, Lancet ii: 798 (1989).

    Article  Google Scholar 

  3. H.J. Alter, Transfusion-associated non-A, non-B hepatitis: the first decade, in: “Viral hepatitis and liver disease”, A.J. Zuckerman, ed, A.R. Liss, New York (1988).

    Google Scholar 

  4. R.L. Koretz, O. Stone, M. Mousa, G.L. Gitnik, Non-A, non-B post-transfusion hepatitis. A decade later, Gastroenterology 88: 1251 (1985).

    PubMed  CAS  Google Scholar 

  5. W.H. Caselmann, J. Eisenburg, P.H. Hofschneider, R. Koshy, ß and γ-interferon in chronic active hepatitis B. A pilot trial of short term combination therapies, Gastroenterology 96: 449 (1989).

    PubMed  CAS  Google Scholar 

  6. A. Biliau, The clinical application of fibroblast interferon. An overview, Med Oncol & Tumor Pharmacother 1: 87 (1984).

    Google Scholar 

  7. K. Ohnishi, F. Nomura, S. Lida, Treatment of post-transfusion non-A, non-B acute and chronic hepatitis with human fibroblast 6-interferon: A preliminary report, Am J Gastroenterol 84: 596 (1989).

    PubMed  CAS  Google Scholar 

  8. K. Chayama, S. Saiton, Y. Arase, K. Ikeda, T. Matsumoto, Y. Sakai, M. Kobayashi, M. Unakami, T. Morinaga, H. Kumada, Effect of interferon administration on serum hapatitis C virus RNA in patients with chronic hepatitis C, Hepatology 13: 1040 (1991).

    Article  PubMed  CAS  Google Scholar 

  9. D.M. Campoli-Richards, E.M. Sorkin, R.C. Heel, Inosine pranobex: a preliminary review of its pharmacodynamics and pharmacokinetics properties, and therapeutic efficacy, Drugs 32: 383 (1986).

    Article  PubMed  CAS  Google Scholar 

  10. W. Prohasca, K. Kleesiek, Treatment of chronic hepatitis C with inosine pranobex, Lancet 338: 390 (1991).

    Article  Google Scholar 

  11. D. Sansonno, P. Detomaso, M.A. Papanice, G. Fiore, G. Bufano, O.G. Manghisi, Correlation between hepatitis B virus deoxyribonucleic acid and receptors for polymerized human albumine in HBV chronic infection, Digestion 37: 206 (1987).

    Article  PubMed  CAS  Google Scholar 

  12. G.L. Davis, L.A. Balart, E.R. Schiff, K. Lindsay, H.C. Bodenheimer, R.P. Perrillo, W. Carey, I.M. Jacobson, J. Payne, J.L. Dienstag, D.H. Vanthiel, C. Tamburro, J.Lefkowitch, J. Albrecht, C. Meschievitz, T.J. Ortego, A.Gibas, Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. N Engl J Med 321: 1501 (1989).

    Article  PubMed  CAS  Google Scholar 

  13. X. Causse, H. Godinot, M. Chevallier, P. Chossegros, F. Zoulin, D. Ouzan, J-P. Heyraud, T. Fontanges, J. Albrecht, C. Meschievitz, C. Trepo, Comparison of 1 or 3 MU of Interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis. Gastroenterology 101: 497 (1991).

    PubMed  CAS  Google Scholar 

  14. D. Sansonno, V. Cornacchiulo, P. Gatti, F. Dammacco, Circulating levels and liver tissue distribution of intercellular adhesion molecule-1 during ß-interferon therapy of hepatitis C virus-associated chronic active disease, Int J Clin Lab Res 22: 100 (1992).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer Science+Business Media New York

About this chapter

Cite this chapter

Sansonno, D., Azzolini, C., Dammacco, F. (1993). Treatment of Hepatitis C Virus-Associated Chronic Liver Disease with ß-Interferon and Inosine Pranobex: Combination Schedule vs Monotherapies. In: Garaci, E., Goldstein, A.L. (eds) Combination Therapies 2. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2964-4_25

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-2964-4_25

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6289-0

  • Online ISBN: 978-1-4615-2964-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics